On April 9–10, 2026, a Cook County jury delivered one of the most significant product liability verdicts in infant formula litigation history — a $70 million judgment against Abbott Laboratories over its Similac Special Care formula and its link to necrotizing enterocolitis (NEC) in premature infants. For families navigating this legal landscape, understanding how that $70 million was calculated — and how damages might apply to your own case — is critical. This guide breaks down the verdict, explains the infant formula NEC verdict Abbott damage calculator methodology used in product liability cases, and provides a framework for estimating compensation in similar NEC lawsuits.
The April 2026 Cook County Verdict: What Happened
A Cook County jury returned a $70 million verdict against Abbott Laboratories in April 2026, finding the company responsible for NEC injuries suffered by premature infants who were fed Similac Special Care formula. The verdict included $53 million in compensatory damages and $17 million in punitive damages after jurors found that Abbott’s cow’s milk-based formula contributed to the infants developing NEC. The split between these two damage categories reveals exactly how juries weigh ongoing harm against corporate wrongdoing in product liability cases.
After ten hours of deliberation, an Illinois jury awarded $53 million in compensatory damages to four mothers whose preterm infants had been diagnosed with NEC — a severe gastrointestinal illness — after being fed Abbott’s cow’s milk-based Similac Special Care 24 baby formula at hospitals in the Chicago area. The plaintiffs alleged that Abbott had concealed evidence from regulators and the public that the formula could cause NEC, resulting in long-term damage to the babies, including surgery in the initial weeks after they were born.
The verdict marks the first NEC baby formula case to go to trial in Illinois and represents a significant development in the ongoing litigation against manufacturers of cow’s milk-based infant formulas. In a statement, Abbott said it “respectfully but strongly” disagreed with the verdict and would appeal. To understand how courts measure compensation under product liability law, it helps to examine each damage category in detail.
How the $53 Million in Compensatory Damages Was Calculated
Compensatory damages in an infant formula NEC case are designed to make the injured party “whole” — meaning they cover every measurable loss the family has suffered. The $53 million compensatory portion of the Cook County verdict was spread across four consolidated cases, suggesting an average compensatory award approaching $13 million per family depending on the severity of each child’s injuries. The severity of an infant’s condition, the extent of medical intervention required, and the long-term impact on a child’s life are all critical factors in determining the appropriate compensation to be claimed. Tangible losses, such as medical expenses, can give families some idea of where they might fall within these ranges, but the full calculation of losses — including non-economic damages like pain and suffering — requires professional legal assessment. Using this verdict as a benchmark is exactly the kind of analysis our infant formula NEC verdict Abbott damage calculator methodology applies to individual cases.
Medical Costs in NEC Cases
NEC medical expenses are among the most catastrophic in pediatric medicine. Premature infants who develop NEC typically require emergency surgery, extended NICU stays, bowel resections, and — in surviving cases — lifelong nutritional and gastrointestinal management. Historical claims data reveals significant variability in NICU daily rates, with charges ranging from $3,000 to as high as $60,000 per day for the same level of infant care. The average cost of a NICU stay is around $70,000; however, a complex single case can easily exceed $1 million.
Level of care dramatically shapes those costs. Level II special care nurseries for moderately premature babies are commonly estimated at $3,000 to $5,000 per day in billed charges. Level III NICUs, providing sustained life support such as ventilators and advanced imaging, run approximately $5,000 to $8,000 per day. Level IV regional NICUs — the highest capability, including newborn surgery — can exceed $10,000 per day. A short special-care stay of about two weeks may run roughly $75,000 in billed charges, while a long stay for a very premature infant (born before 28 weeks) can reach several hundred thousand dollars, and the most severe, months-long cases can exceed $1,000,000.
The population most at risk for NEC is increasing because with technological advances in care the number of very low birth weight (VLBW) infants who survive continues to grow, while the percentage of VLBW infants who develop NEC remains steady at about 7%. NEC is one of the leading causes of illness and death among preterm infants, and 15–40 percent of infants with NEC die from the disease. In NEC cases that require surgical intervention — particularly bowel resection — additional hospitalizations, follow-up surgeries, and permanent nutritional support compound the lifetime medical cost substantially.
Pain and Suffering Damages in NEC Litigation
Non-economic damages for pain and suffering are among the most difficult components to quantify in any personal injury case, but NEC litigation has produced some of the largest non-economic awards in pediatric product liability history. In the Cook County verdict, jurors were asked to put a dollar value on the physical suffering experienced by premature infants undergoing emergency bowel surgery, the emotional trauma endured by their parents, and — in survival cases — the ongoing pain of living with short bowel syndrome or other chronic conditions. The damages were intended to compensate for loss of a normal life and the risk of future complications, as well as for pain and suffering.
The Missouri appellate courts have provided a critical benchmark for how pain and suffering awards hold up on review. A Missouri appellate court has upheld a $495 million verdict against Abbott Laboratories in a major NEC baby formula case, affirming the 2024 Gill verdict, where a jury found that Abbott’s cow’s milk-based premature infant formula, Similac Special Care 24, contributed to a premature infant developing NEC. The award includes $95 million in compensatory damages and $400 million in punitive damages. The jury reached its verdict following a three-week-long trial during which the plaintiff alleged her daughter was given Abbott’s formula for premature infants after she was born at 26 weeks gestation, causing her to develop NEC. The child underwent extensive surgery because of her NEC diagnosis and continues to suffer from long-term health issues.
Breaking Down the $17 Million in Punitive Damages
The $17 million punitive damages component of the Cook County verdict requires separate analysis because it answers a different legal question: not “how much did the plaintiffs lose?” but “how badly did Abbott behave?” Verdicts may include compensatory damages for financial losses and punitive damages meant to penalize the defendant. Punitive damages may exceed compensatory damages — for example, a July 2024 baby formula trial resulted in $95 million compensatory and $400 million punitive damage awards to the family of an infant who developed NEC.
In the Cook County case, the $17 million punitive award represents a roughly 1-to-3.2 ratio against the $53 million compensatory award — a ratio that comfortably survives constitutional scrutiny under the U.S. Supreme Court’s due process analysis. The Missouri appellate court rejected Abbott’s “learned intermediary” defense, ruling that preterm infant formula is considered food, not a prescription medical product. This classification is important for punitive damages: it means juries can hold Abbott to the standard of a food manufacturer that sells directly to consumers, rather than the narrower standard applied to prescription drug makers whose warnings are directed at physicians.
Plaintiffs argued Abbott knew or should have known about the heightened danger for infants weighing less than 1,500 grams but failed to include stronger NEC warnings on its formula labeling. Jurors were shown examples of warning language that plaintiffs argued should have appeared on the product, specifically referencing the risks of necrotizing enterocolitis. Current labeling for Similac Special Care 24 states that human milk is recommended and advises users to follow physicians’ instructions, but does not specifically warn about NEC.
The appellate court’s May 2026 affirmance of the $495 million Missouri verdict — including its $400 million punitive component — sends a powerful signal about how appellate courts are treating these punitive awards. The court found the plaintiff had enough evidence for the jury to decide that Abbott’s formula caused or contributed to the child’s NEC, pointing to expert testimony, medical records, the timing of NEC symptoms after formula exposure, and studies showing sharply increased NEC risk in very low birthweight infants fed preterm formula.
NEC Litigation Landscape: 800+ Pending Cases in 2026
The Cook County verdict did not emerge from a vacuum — it is one data point in a rapidly expanding national litigation that now spans both federal multidistrict proceedings and state courts across the country. As of July 2026, there were 810 active baby formula necrotizing enterocolitis lawsuits pending in MDL 3026 before U.S. District Judge Rebecca Pallmeyer in the Northern District of Illinois. Roughly 780 federal NEC lawsuits remained pending in MDL No. 3026 in the Northern District of Illinois as of spring 2026, with hundreds more cases proceeding in state courts across the country.
Abbott won the first three federal bellwether trials on summary judgment in 2025, with Judge Pallmeyer excluding plaintiffs’ causation experts under the rigorous Daubert standard in each instance. Those rulings created headwinds in federal court, but they have not slowed state court litigation. The Cook County verdict is the latest in a series of wins for plaintiffs in state court — a very different picture from what has happened in federal court, where cases have often stalled.
The federal MDL is now accelerating. After years of delay, the first federal bellwether trial in the infant formula NEC MDL moved forward with Judge Pallmeyer clearing the path for the first bellwether — an Enfamil case brought by a man whose son, Daniel, died just days after birth, set to go to trial on July 6, 2026. A second trial involving Similac claims brought by a California family whose premature daughter suffered permanent injuries follows on August 10, 2026. The federal court managing the NEC MDL has also scheduled additional bellwether trials for November 2026 and February 2027.
Critically, a significant legal development in June 2026 reshapes the warning-duty landscape for some plaintiffs. In what is believed to be the first ruling by any appellate court on the issue, an Illinois intermediate appellate court reversed a multi-million-dollar verdict and held that the learned intermediary doctrine applies to infant formula used exclusively in a hospital setting under physician oversight. The formal absence of an FDA prescription requirement does not determine the analysis — the clinical context does. In June 2026, an Illinois appellate court reversed the $60 million verdict against Mead Johnson in the Watson case. The case involved a premature baby who died in 2020 at 25 days old after being fed Enfamil premature infant formula in the hospital. The Fifth District Court of Appeal sent the case back for a new trial, ruling that the trial judge should have applied the learned intermediary doctrine.
Despite that setback, the overall verdict pressure on manufacturers continues to mount. NEC baby formula litigation now involves three big jury verdicts in state court totaling $630 million. Despite multiple enormous jury verdicts against formula manufacturers, no global settlement has been announced in the NEC litigation, though analysts and plaintiff attorneys continue to speculate that mounting verdict pressure could eventually push Abbott and Mead Johnson toward broader settlement negotiations.
Using an Infant Formula NEC Damage Calculator: What Factors Matter
An infant formula NEC verdict Abbott damage calculator is not a literal online tool — it is a methodology that experienced NEC attorneys use to build a damages estimate for an individual case by applying the variables that juries have consistently weighted in actual verdicts. Here is how the key inputs work:
Economic Damage Inputs
Past medical expenses: Every bill from the initial NICU stay, surgeries, follow-up hospitalizations, and specialist visits is included. Length of stay drives the total more than anything else. Average NICU stays are often cited in the range of about 13 to 25 days, but very premature babies can stay for months. In NEC cases, NICU stays are typically extended far beyond the baseline premature birth stay due to surgical recovery, infection management, and total parenteral nutrition (TPN) dependence.
Future medical expenses: NEC survivors who undergo bowel resection frequently develop short bowel syndrome, requiring permanent IV nutrition, intestinal transplant evaluation, and lifelong GI specialist care. Expert life care planners calculate this figure using actuarial tables, current medical pricing, and inflation projections. In cases from the Cook County verdict, where infants survived but suffered long-term health effects, these future cost projections constituted a substantial portion of compensatory damages.
Lost wages and out-of-pocket expenses: Factors that affect compensation in NEC baby formula lawsuits include medical costs, lost wages, and out-of-pocket expenses related to NEC injury or death. Parents who leave employment to provide full-time care for an NEC survivor are entitled to document lost earning capacity as a recoverable economic loss.
Non-Economic Damage Inputs
Pain and suffering: Juries place a monetary value on the pain experienced by the infant during and after NEC onset — which typically includes emergency surgery, intestinal necrosis, and sepsis — and on the parent’s emotional suffering.
Loss of normal life: For surviving infants, this category covers the activities and milestones the child will never experience due to permanent gastrointestinal disability. Non-fatal NEC injury payouts in settlement contexts could range from $50,000 to $600,000 for less severe injuries. A case with a child who develops NEC and has a permanent disability may receive a settlement between $1 million and $10 million.
Wrongful death damages: In fatal NEC cases, the damage model shifts to include loss of society, loss of companionship, and parental grief. In fatal NEC cases where an infant did not survive, families navigating the financial dimensions of a wrongful death claim may benefit from understanding how courts have historically valued similar losses, including loss of future companionship and parental grief damages.
Punitive Damage Variables
Punitive damages in NEC litigation hinge on what the defendant knew and when. Courts have found there was enough evidence for a jury to conclude that Abbott’s formula caused or contributed to NEC, and appellate decisions have highlighted evidence that Abbott knew very low birthweight babies faced a greater NEC risk but did not clearly warn about that danger. Evidence of manufacturer negligence could also play a significant role in influencing the final settlement, potentially increasing the compensation awarded.
The punitive-to-compensatory ratio matters. The Cook County verdict’s approximately 1:3.2 punitive-to-compensatory ratio is well within constitutional limits under BMW of North America v. Gore and State Farm v. Campbell. The Missouri $495 million verdict’s roughly 4:1 punitive ratio ($400M punitive vs. $95M compensatory) was upheld on appeal precisely because the appellate court found sufficient evidence of egregious conduct. Punitive damages are awarded specifically to punish defendants for particularly egregious conduct — findings that, when upheld on appeal, carry significant weight in mass tort settlement negotiations.
Legal Impact and What This Verdict Means for Pending NEC Cases
The April 2026 Cook County verdict carries outsized strategic weight for several reasons that go beyond its dollar amount. First, it is the first multi-family Illinois state court verdict in this litigation — a jurisdictional milestone because both Abbott and Mead Johnson are headquartered in Illinois, making venue challenges difficult. Both Mead Johnson and Abbott are based in Illinois, which means neither company can credibly object to being sued there. That jurisdictional advantage, combined with Illinois courts’ willingness to admit out-of-state attorneys and the state’s generally plaintiff-friendly legal landscape, has made Illinois an attractive filing destination for families from across the country.
Second, the verdict survived the learned intermediary challenge that derailed the Watson/Mead Johnson verdict. The Cook County jury found Abbott liable on the same failure-to-warn theory that the Fifth District later applied the learned intermediary doctrine to in Watson — but the Cook County trial court apparently handled those jury instructions differently. The learned intermediary ruling is significant for Mead Johnson, and one the defense will try to use in other NEC cases. But it is also a controversial expansion of the learned intermediary doctrine — this was not a prescription medication; it was infant formula. Applying a doctrine built around doctors prescribing drugs to a nutrition product given to premature babies in hospitals gives the defense a new legal argument that could limit direct warning claims by parents.
Third, the May 2026 affirmance of the $495 million Missouri verdict strips Abbott of its strongest appellate argument. The appellate ruling rejected key defense arguments from Abbott Laboratories and could influence future NEC baby formula lawsuits involving premature infants and cow’s milk-based formula products. This decision will not guarantee wins, but it strengthens the plaintiffs’ playbook and weakens several defenses Abbott once thought were strong.
Abbott has proposed a second round of bellwether trials in the federal MDL, with three new test cases planned for August 2026, November 2026, and February 2027. The outcome of those federal trials — particularly the first Enfamil case involving an infant death — will likely determine whether Abbott and Mead Johnson move toward a global settlement or continue fighting cases individually. There is a real chance that a settlement is on the horizon.
Frequently Asked Questions About the Abbott NEC Verdict and Damage Calculations
What is the infant formula NEC verdict and how does it affect my case?
The April 2026 Cook County verdict is a $70 million judgment against Abbott Laboratories, finding the company liable for NEC injuries in four premature infants fed Similac Special Care 24 formula. The company noted the verdict could lead to more trials with multiple plaintiffs. While no verdict automatically creates precedent for settlement amounts in individual cases, each NEC baby formula lawsuit is different. Large multi-million-dollar jury verdicts in state courts are outliers, so they aren’t necessarily going to predict what an individual settlement amount would be. What the verdict does is demonstrate that Illinois juries are willing to hold Abbott accountable on failure-to-warn grounds, which strengthens the bargaining position of all plaintiffs with similar facts.
How are compensatory damages calculated in an NEC lawsuit against Abbott?
Compensatory damages are calculated by adding all economic losses (past and future medical costs, lost parental income, out-of-pocket expenses) to all non-economic losses (pain and suffering, loss of normal life, loss of society). It’s impossible to determine an exact amount that an NEC baby formula lawsuit could reach because each case is unique. However, payouts are generally influenced by the severity of the injury and previous verdicts or settlements. The Cook County verdict’s $53 million compensatory award across four families — with infants who survived but suffered permanent effects — suggests that severe-injury survival cases can command compensatory awards in the $10–$15 million range per plaintiff when tried before a jury.
Why did the jury award $17 million in punitive damages against Abbott?
Punitive damages require proof that the defendant acted with knowledge of a substantial risk and consciously disregarded that risk. The plaintiffs alleged that Abbott concealed evidence from regulators and the public that the formula could cause NEC, resulting in long-term damage to the babies. The jury found this evidence sufficient to warrant punishment beyond compensatory damages. The $17 million punitive award — approximately 32 cents for every dollar of compensatory damages — is conservative by NEC litigation standards. The jury ultimately concluded that Abbott’s conduct warranted substantial punitive damages in addition to compensation for the children’s lifelong injuries.
How many NEC lawsuits are pending against Abbott and Mead Johnson in 2026?
As of July 2026, there were 810 active baby formula necrotizing enterocolitis lawsuits pending in MDL 3026 before U.S. District Judge Rebecca Pallmeyer in the Northern District of Illinois. Roughly 780 federal NEC lawsuits remained pending in MDL No. 3026 in the Northern District of Illinois, with hundreds more cases proceeding in state courts across the country. The Illinois Appellate Court has also affirmed that thousands of NEC-related lawsuits against Abbott Laboratories and Mead Johnson should remain in Madison County, Illinois — a jurisdiction often viewed as favorable to plaintiffs — rejecting the companies’ attempts to transfer the cases to other venues.
What is the statute of limitations for filing an NEC lawsuit?
State governments set the statute of limitations for product liability lawsuits such as the NEC infant formula lawsuits. The deadline to file an NEC baby formula lawsuit varies by state, and the child may have more time to bring a claim than the parents. The statute of limitations to file an NEC lawsuit is a complicated question. In Illinois, product liability claims are generally subject to a two-year statute of limitations from the date of injury or discovery, but the discovery rule and minor tolling provisions can extend that window significantly for cases involving premature infants. Abbott has agreed to accept service and waive statute-of-limitations defenses for plaintiffs who refile in their home states following certain court-ordered dismissals. Families should consult a qualified NEC attorney immediately, as filing deadlines vary by jurisdiction and continue to run regardless of ongoing litigation developments. The litigation is nearing an important phase. If you have a claim, you want to act now.
James Mitchell is a personal injury legal researcher with over a decade of experience analyzing settlement data and compensation trends across the United States. He has studied thousands of personal injury cases to help injury victims understand their legal rights and the potential value of their claims. James is not an attorney and the information he provides is for
educational purposes only.